The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development

Francesca Bernassola, Michael Karin, Aaron Ciechanover, Gerry Melino

Research output: Contribution to journalArticle

Abstract

The involvement of the homologous to E6-AP carboxyl terminus (HECT)-type E3s in crucial signaling pathways implicated in tumorigenesis is presently an area of intense research and extensive scientific interest. This review highlights recent discoveries on the ubiquitin-mediated degradation of crucial tumor suppressor molecules catalyzed by the HECT-type E3s. By providing a portrait of their protein targets, we intend to link the substrate specificity of HECT-type E3s with their contribution to tumorigenesis. Moreover, we discuss the relevance of targeting the HECT E3s, through the development of small-molecule inhibitors, as an anticancer therapeutic strategy.

Original languageEnglish
Pages (from-to)10-21
Number of pages12
JournalCancer Cell
Volume14
Issue number1
DOIs
Publication statusPublished - Jul 8 2008

Fingerprint

Ubiquitin-Protein Ligases
Carcinogenesis
Ubiquitin
Substrate Specificity
Neoplasms
Research
Proteins
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

The HECT Family of E3 Ubiquitin Ligases : Multiple Players in Cancer Development. / Bernassola, Francesca; Karin, Michael; Ciechanover, Aaron; Melino, Gerry.

In: Cancer Cell, Vol. 14, No. 1, 08.07.2008, p. 10-21.

Research output: Contribution to journalArticle

@article{b43f4a2be4be414895cca772326c1ac8,
title = "The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development",
abstract = "The involvement of the homologous to E6-AP carboxyl terminus (HECT)-type E3s in crucial signaling pathways implicated in tumorigenesis is presently an area of intense research and extensive scientific interest. This review highlights recent discoveries on the ubiquitin-mediated degradation of crucial tumor suppressor molecules catalyzed by the HECT-type E3s. By providing a portrait of their protein targets, we intend to link the substrate specificity of HECT-type E3s with their contribution to tumorigenesis. Moreover, we discuss the relevance of targeting the HECT E3s, through the development of small-molecule inhibitors, as an anticancer therapeutic strategy.",
author = "Francesca Bernassola and Michael Karin and Aaron Ciechanover and Gerry Melino",
year = "2008",
month = "7",
day = "8",
doi = "10.1016/j.ccr.2008.06.001",
language = "English",
volume = "14",
pages = "10--21",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - The HECT Family of E3 Ubiquitin Ligases

T2 - Multiple Players in Cancer Development

AU - Bernassola, Francesca

AU - Karin, Michael

AU - Ciechanover, Aaron

AU - Melino, Gerry

PY - 2008/7/8

Y1 - 2008/7/8

N2 - The involvement of the homologous to E6-AP carboxyl terminus (HECT)-type E3s in crucial signaling pathways implicated in tumorigenesis is presently an area of intense research and extensive scientific interest. This review highlights recent discoveries on the ubiquitin-mediated degradation of crucial tumor suppressor molecules catalyzed by the HECT-type E3s. By providing a portrait of their protein targets, we intend to link the substrate specificity of HECT-type E3s with their contribution to tumorigenesis. Moreover, we discuss the relevance of targeting the HECT E3s, through the development of small-molecule inhibitors, as an anticancer therapeutic strategy.

AB - The involvement of the homologous to E6-AP carboxyl terminus (HECT)-type E3s in crucial signaling pathways implicated in tumorigenesis is presently an area of intense research and extensive scientific interest. This review highlights recent discoveries on the ubiquitin-mediated degradation of crucial tumor suppressor molecules catalyzed by the HECT-type E3s. By providing a portrait of their protein targets, we intend to link the substrate specificity of HECT-type E3s with their contribution to tumorigenesis. Moreover, we discuss the relevance of targeting the HECT E3s, through the development of small-molecule inhibitors, as an anticancer therapeutic strategy.

UR - http://www.scopus.com/inward/record.url?scp=45849153870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45849153870&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2008.06.001

DO - 10.1016/j.ccr.2008.06.001

M3 - Article

C2 - 18598940

AN - SCOPUS:45849153870

VL - 14

SP - 10

EP - 21

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 1

ER -